Clinical trial
A Phase 2, MultiCenter, Randomized, Placebo-Controlled, Double-Blind, Dose Finding Study to Determine the Safety and Efficacy of SCH 619734 for the Treatment of Chemotherapy Induced Nausea and Vomiting (CINV) in Subjects Receiving Highly Emetogenic Chemotherapy (HEC)
NCT00394966 is registered in ClinicalTrials.gov with Schering-Plough as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 2, MultiCenter, Randomized, Placebo-Controlled, Double-Blind, Dose Finding Study to Determine the Safety and Efficacy of SCH 619734 for the Treatment of Chemotherapy Induced Nausea and Vomiting (CINV) in Subjects Receiving Highly Emetogenic Chemotherapy (HEC)
- Lead sponsor
- Schering-Plough
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- September 30, 2006
- Completion date
- March 31, 2008
- Enrollment
- 450 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.